Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPT | AZN | AMGN | GILD | BMY |
| Company | Rapt Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 57.70 | 190.46 | 369.99 | 149.69 | 59.92 |
| High | 57.70 | 191.06 | 376.17 | 150.12 | 61.50 |
| Low | 57.68 | 190.23 | 369.99 | 149.11 | 59.87 |
| Latest | 57.73 | 190.01 | 373.80 | 149.76 | 60.85 |
| Change | +0.05 | +2.85 | +6.00 | +0.39 | +1.33 |
| % Change | +0.09% | +1.52% | +1.63% | +0.26% | +2.23% |
| Volume | 212,526 | 21,351 | 14,258 | 56,201 | 144,957 |
| 20-Day Average Volume | 3,980,556 | 8,705,107 | 2,895,073 | 7,744,480 | 12,631,748 |
| Previous Close | 57.68 | 187.16 | 367.80 | 149.37 | 59.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 50.57 | 116.97 | 342.62 | 134.36 | 55.96 |
| 20-Day Raw Stochastic | 99.34% | 98.26% | 98.50% | 96.74% | 96.48% |
| 20-Day Relative Strength | 76.29 | 88.53 | 69.09 | 75.10 | 72.33 |
| Weighted Alpha | +237.35 | +68.67 | +36.85 | +61.76 | +21.64 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.02% since 01/30/26 | +105.87% since 01/30/26 | +9.78% since 01/30/26 | +5.31% since 01/30/26 | +11.21% since 01/30/26 |
| Low | 57.61 on 02/04/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 140.01 on 02/02/26 | 54.96 on 02/02/26 |
| High | 57.86 on 02/04/26 | 192.79 on 02/02/26 | 376.17 on 02/06/26 | 150.50 on 02/05/26 | 61.50 on 02/06/26 |
| 1-Month | |||||
| %Chg | +87.12% since 01/06/26 | +101.12% since 01/06/26 | +13.68% since 01/06/26 | +23.17% since 01/06/26 | +12.50% since 01/06/26 |
| Low | 31.08 on 01/07/26 | 89.04 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 57.86 on 02/04/26 | 192.79 on 02/02/26 | 376.17 on 02/06/26 | 150.50 on 02/05/26 | 61.50 on 02/06/26 |
| 3-Month | |||||
| %Chg | +98.66% since 11/06/25 | +127.99% since 11/06/25 | +18.93% since 11/06/25 | +21.14% since 11/06/25 | +31.29% since 11/06/25 |
| Low | 26.50 on 11/21/25 | 84.22 on 11/07/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 57.86 on 02/04/26 | 192.79 on 02/02/26 | 376.17 on 02/06/26 | 150.50 on 02/05/26 | 61.50 on 02/06/26 |
| 6-Month | |||||
| %Chg | +477.48% since 08/06/25 | +159.49% since 08/06/25 | +31.85% since 08/06/25 | +35.55% since 08/06/25 | +36.59% since 08/06/25 |
| Low | 8.75 on 08/12/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 57.86 on 02/04/26 | 192.79 on 02/02/26 | 376.17 on 02/06/26 | 150.50 on 02/05/26 | 61.50 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,598,371 | 290,267,936 | 198,053,312 | 185,320,384 | 121,168,016 |
| Shares Outstanding, K | 27,711 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -129,870,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -17,580,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.47 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.65 on 11/06/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/05/26 | 02/10/26 | 05/07/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.51 | 16.76 | 17.85 | 8.78 |